WilmerHale Advises Thermo Fisher on its Inaugural CHF 1.070 Billion Offering of Bonds

WilmerHale Advises Thermo Fisher on its Inaugural CHF 1.070 Billion Offering of Bonds

Client News

Related Solutions

Leveraging our sophisticated technical, market and legal experience to help clients effectively and efficiently manage complex transactions and get the deal done.
Advising life sciences innovators, investors and industry leaders on complex transactions, legal issues and business challenges.
A deep and diverse practice focused on maximizing tax efficiencies and minimizing tax risks for clients nationally and internationally.

WilmerHale acted as US special counsel to Thermo Fisher Scientific Inc. in connection with its inaugural offer and sale of CHF-denominated bonds, in an offering that was the largest issuance by a foreign issuer of Swiss franc bonds in seven years. The offering consisted of CHF 330,000,000 aggregate principal amount of 1.6525% Bonds due 2028, CHF 415,000,000 aggregate principal amount of 1.8401% Bonds due 2032 and CHF 325,000,000 aggregate principal amount of 2.0375% Bonds due 2036, each to be listed on the SIX Swiss Exchange. The offering priced on February 27, 2024 and closed on March 7, 2024. UBS AG, acting through its business division, UBS Investment Bank, BNP Paribas (Suisse) SA and Deutsche Bank AG London Branch, acting through Deutsche Bank AG Zurich Branch, acted as the joint lead managers for the offering. 

The WilmerHale team advising Thermo Fisher Scientific Inc. on the offering consisted of Molly Fox, Justin Ochs, Andrew Langworthy, Ryan S. Brewer and Rachael Joseph (Capital Markets), with assistance from Julie Hogan-Rodgers (Tax).

Notice

We appreciate your interest in WilmerHale. While we are pleased to have you contact us, please keep in mind that merely contacting WilmerHale does not create an attorney-client relationship. Such a relationship will not arise until the Firm agrees in writing to represent you in connection with a particular matter. Importantly, unless and until this has occurred, you should not provide us with any confidential information, and we have no duty to keep confidential any information that we may receive from you. Thank you for your understanding.

I Accept Cancel